Short Interest in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Grows By 20.0%

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the recipient of a large increase in short interest during the month of January. As of January 30th, there was short interest totaling 26,360,014 shares, an increase of 20.0% from the January 15th total of 21,965,300 shares. Based on an average daily volume of 4,378,165 shares, the days-to-cover ratio is presently 6.0 days. Approximately 29.2% of the company’s shares are sold short. Approximately 29.2% of the company’s shares are sold short. Based on an average daily volume of 4,378,165 shares, the days-to-cover ratio is presently 6.0 days.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ACHC. Principal Financial Group Inc. raised its position in shares of Acadia Healthcare by 112.1% in the third quarter. Principal Financial Group Inc. now owns 442,943 shares of the company’s stock valued at $10,967,000 after purchasing an additional 234,107 shares during the period. Envestnet Portfolio Solutions Inc. grew its stake in Acadia Healthcare by 256.4% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 26,053 shares of the company’s stock valued at $591,000 after buying an additional 18,742 shares in the last quarter. First Citizens Bank & Trust Co. grew its stake in Acadia Healthcare by 164.1% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 59,123 shares of the company’s stock valued at $1,464,000 after buying an additional 36,733 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its position in shares of Acadia Healthcare by 85.1% during the second quarter. Oppenheimer Asset Management Inc. now owns 28,683 shares of the company’s stock worth $651,000 after acquiring an additional 13,188 shares in the last quarter. Finally, Caxton Associates LLP boosted its holdings in shares of Acadia Healthcare by 1,234.5% in the second quarter. Caxton Associates LLP now owns 173,482 shares of the company’s stock worth $3,936,000 after acquiring an additional 160,482 shares during the period.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ACHC. Guggenheim cut their target price on shares of Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating on the stock in a research note on Monday, November 10th. KeyCorp cut their price objective on shares of Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a research report on Wednesday, December 3rd. Deutsche Bank Aktiengesellschaft decreased their target price on Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating for the company in a research report on Wednesday, December 3rd. Barclays cut their price target on Acadia Healthcare from $17.00 to $14.00 and set an “equal weight” rating on the stock in a report on Thursday, December 4th. Finally, Jefferies Financial Group downgraded Acadia Healthcare to a “hold” rating in a report on Thursday, January 22nd. Six research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $18.62.

Acadia Healthcare Trading Up 3.1%

NASDAQ:ACHC opened at $16.93 on Thursday. Acadia Healthcare has a 52 week low of $11.43 and a 52 week high of $42.85. The firm has a 50-day moving average price of $14.14 and a two-hundred day moving average price of $18.58. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.44 and a current ratio of 1.44. The firm has a market cap of $1.56 billion, a price-to-earnings ratio of 14.47, a price-to-earnings-growth ratio of 4.67 and a beta of 0.89.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.